Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Anti-Thyroid Drugs Market, and What Are the Key Drivers?

In recent years, there has been a consistent expansion in the size of the anti-thyroid drugs market. The market, which is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 2.2%. The previous period’s growth can be credited to the widespread incidence of thyroid disorders, advancements in medicine creation, and the development of healthcare structures.

The market size for anti-thyroid drugs is forecasted to exhibit solid expansion in the coming years, reaching a value of $2.78 billion in 2029 with a CAGR of 2.7%. This growth during the predicted timeframe can be credited to factors such as increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. Notably, the period is expected to see major trends such as alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, and the adoption of telemedicine and remote monitoring.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the Anti-Thyroid Drugs Market?

The rise in cases of Graves’ disease, which is an immediate cause of hyperthyroidism, has been observed. The US-based National Library of Medicine, owned by the United States federal government, states that Graves’ disease (GD) is the leading cause of hyperthyroidism in developed nations. GD is typically prevalent among those aged between 30 and 60, with women being 5-10 times more vulnerable than men. A 79% genetic predisposition is related to the risk for GD, while 21% is attributable to environmental factors. The rise in Graves’ disease cases is causing an increase in hyperthyroidism sufferers. This has led to a surge in demand for anti-thyroid drugs, thereby propelling the market’s growth.

Request Your Free Anti-Thyroid Drugs Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Companies Are Leading the Charge in Expanding the Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

What New Trends Are Reshaping the Anti-Thyroid Drugs Market and Its Opportunities?

Organizations dedicated to thyroid health are stepping up efforts to promote knowledge on thyroid conditions, the latest therapy options, and recent findings in thyroid disorder research. It’s estimated that around 60% of hyperthyroidism sufferers in the USA are undiagnosed and uninformed about their condition. To tackle this problem, several associations such as the American Thyroid Association (ATA) have embarked on educational campaigns about thyroid disorders. Likewise, the Thyroid Foundation of Canada is taking measures to raise public curiosity and consciousness about thyroid diseases, including hyperthyroidism. Other bodies, like the American Academy of Otolaryngology and the British Thyroid Foundation, are implementing awareness and outreach initiatives too.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Key Market Segments Comprise the Anti-Thyroid Drugs Market and Drive Its Revenue Growth?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

What Are the Top Regions Fueling Growth in the Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Anti-Thyroid Drugs Market?

Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

Browse Through More Similar Reports By The Business Research Company:

Diuretics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

Genito-Urinary Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Drugs for Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: